{"id":3709,"date":"2021-12-28T12:00:57","date_gmt":"2021-12-28T03:00:57","guid":{"rendered":"https:\/\/hbio.jp\/news\/?p=3709"},"modified":"2022-08-12T12:09:34","modified_gmt":"2022-08-12T03:09:34","slug":"notice-on-capital-increase-through-the-third-party-allocation","status":"publish","type":"post","link":"https:\/\/hbio.jp\/news\/en\/2021\/12\/28\/notice-on-capital-increase-through-the-third-party-allocation\/","title":{"rendered":"Notice on capital increase through the third-party allocation"},"content":{"rendered":"<p class=\"wp-block-paragraph\"> HIROTSU BIO SCIENCE INC. recently increased its capital through the allocation of new shares to third parties.  To deliver N-NOSE, a new method that can speed up the detection and treatment of cancer, to many others, we will work to build awareness while also strengthening our test supply system. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\"> \u2192 <a href=\"https:\/\/hbio.jp\/news\/wp-content\/uploads\/2022\/01\/2021228_\u7b2c\u4e09\u8005\u5272\u5f53\u5897\u8cc7_en.pdf\">PRESS RELEASE<\/a> <\/p>","protected":false},"excerpt":{"rendered":"<p>HIROTSU BIO SCIENCE INC. recently increased its capital through the allocation of new shares to third parties. [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_locale":"en_US","_original_post":"3709","footnotes":""},"categories":[3],"tags":[],"class_list":["post-3709","post","type-post","status-publish","format-standard","hentry","category-press-release","en-US"],"acf":[],"_links":{"self":[{"href":"https:\/\/hbio.jp\/news\/en\/wp-json\/wp\/v2\/posts\/3709","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hbio.jp\/news\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hbio.jp\/news\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hbio.jp\/news\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/hbio.jp\/news\/en\/wp-json\/wp\/v2\/comments?post=3709"}],"version-history":[{"count":4,"href":"https:\/\/hbio.jp\/news\/en\/wp-json\/wp\/v2\/posts\/3709\/revisions"}],"predecessor-version":[{"id":3944,"href":"https:\/\/hbio.jp\/news\/en\/wp-json\/wp\/v2\/posts\/3709\/revisions\/3944"}],"wp:attachment":[{"href":"https:\/\/hbio.jp\/news\/en\/wp-json\/wp\/v2\/media?parent=3709"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hbio.jp\/news\/en\/wp-json\/wp\/v2\/categories?post=3709"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hbio.jp\/news\/en\/wp-json\/wp\/v2\/tags?post=3709"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}